Anti-psychotic drug linked to compulsive gambling and other behaviors
The anti-psychotic drug Abilify has been linked to compulsive gambling, shopping, hypersexuality and other risky behaviors, though many in the United States were not aware of those serious side effects due to insufficient warnings given to patients and doctors.
RPWB represents Abilify users nationwide who developed uncontrollable gambling and shopping while taking the drug. Those who experienced these disorders while taking the drug should contact an attorney to discuss their legal rights and the possibility of compensation for gambling losses, healthcare and other expenses.
Even though Abilify’s warning labels in Europe warned patients about pathological gambling since 2012, the drug’s manufacturers omitted this information from labels and patient guides in the United States until 2016.
That means that doctors and patients were not fully aware of the drug’s dangerous side effects when they discussed treatment options, even though the manufacturers, Bristol-Myers and Otsuka Pharmaceutical, had known about them for years.
In the first 13 years Abilify has been on the market in the United States, FDA reporting identified 184 case reports in which there was an association between Abilify use and impulse-control problems. Pathological gambling was the most common (164 cases), but other compulsive behaviors including compulsive eating, spending or shopping, and sexual behaviors were also reported. In the majority of cases, patients with no prior history of the compulsive behaviors experienced uncontrollable urges only after starting treatment.
The manufacturers acknowledged serious reports of pathological gambling in a six-month safety report submitted to the European Medicines Agency in 2011, a full five years before American patients were warned.
From August 2013 to December 2014, the drug companies spent more than $10 million paying doctors to promote Abilify. The companies have spent millions of dollars in direct-to-consumer ads. Promotional materials used by pharmaceutical representatives made no mention of compulsive gambling. In fact, there was no mention of gambling on the drug’s website until January 2016.
In May 2016, the FDA issued a warning that Abilify usage is associated with “compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex.” The previous year, regulators in Canada found an increased risk of pathological (uncontrollable) gambling and hypersexuality with Abilify use.
Bristol-Myers touted Abilify as its “2013 largest-selling product” noting worldwide sales of $2.3 billion. During just a three-month period in 2014, U.S. revenues totaled $417 million. Since its introduction to the United States market, Abilify has generally been used to treat patients with schizophrenia, bipolar disorder, as an adjunct for depression, and autism spectrum disorders.
In 2016, the many Abilify cases filed nationwide were consolidated into what is called a multidistrict litigation, which means that all of the federal cases are moved to a single court so that the process can be streamlined. The cases were consolidated in federal court in the Northern District of Florida in front of Judge M. Casey Rodgers.
On March 13, 2018, Judge Rodgers set trial dates for the first three Abilify lawsuits, which are called bellwether trials. The first case, involving plaintiff Fanny Lyons, will begin on June 18, 2018. The second Abilify lawsuit trial is scheduled for August 6, 2018, involves plaintiffs David Viechec and Cassie Viechec. The third trial on August 27, 2018, involves the Abilify case of Jennifer Lilly. These bellwether trials give attorneys on both sides the opportunity to see how the judge and jurors respond to issues that are common to many of the cases that have been filed to-date.
UPDATE: On 4/30/2018, the parties in the first three bellwether cases reported that they had reached a settlement in all three cases. The parties have indicated that they are working on a global settlement of pending Abilify cases, and are expected to have additional details about the terms of the settlement in the next few months.
Because statutes of limitation might limit the amount of time you have to file a lawsuit, we strongly urge Abilify users who have suffered from compulsive gambling and shopping should contact an attorney to learn about their legal rights.
RPWB represents people throughout the country who developed compulsive behaviors while taking Abilify. Patients and their doctors were not sufficiently warned of the risks, and those who suffered should be compensated.
Our firm is nationally recognized for representing individuals who have been harmed by prescription and non-prescription drugs as well as medical devices. We were named a 2017 Best Law Firm by U.S. News & World Report in the areas of products liability and personal injury litigation. We are a top-listed plaintiff product liability firm as rated by Best Lawyers in America.
RPWB attorneys have been appointed lead counsel in seven large multidistrict litigations and leadership positions in many more. Our team is sensitive to the wishes of our clients yet tenacious and experienced enough to secure maximum compensation.
Our firm has substantial national experience with products liability litigation against drug makers and medical device manufacturers. With respect to pharmaceutical litigation, RPWB attorneys have been appointed lead counsel of seven nationwide multidistrict litigations in recent years. We currently serve or have recently served on various National Plaintiffs’ Steering Committees for consolidated litigation involving: Baycol®, Chantix®, Lipitor®, Ortho Evra®, Phenylpropanolamine (PPA), Rezulin® and Zyprexa®.
Over the years, we have become known for litigating cases against the manufacturers of anti-psychotic drugs. RPWB was in national leadership positions for Chantix and Zyprexa litigation. RPWB was co-lead counsel of Chantix Litigation, which resulted in a $291 million settlement. The Zyprexa litigation settled for $2.1 billion.
Start Your Free Case Review
Give Us A Call
Our Experienced Lawyers
How can we help? Fill out the form for a free case review.
- Toll Free: 888.293.6883
Nov 01, 2019
RPWB is a 2020 U.S. News & World Report Best Law Firm
CHARLESTON, S.C. – U.S. News & World Report has named Richardson, Patrick, Westbrook & Brickman as a 2020 Best Law Firm for the firm’s work in personal injury, mass torts and class actions, product liability, medical malpractice, securities litigation, healthcare law and railroad law. U.S. News’ announcement came on the heels of the 2020 Best […]READ MORE
Oct 25, 2019
Asbestos Find Causes Retailers to Pull Johnson & Johnson Baby Powder
Major retailers including Walmart, CVS and Rite Aid have pulled 22-ounce bottles of Johnson & Johnson Baby Powder after the FDA found traces of asbestos in a recently-tested bottle. The presence of asbestos in Johnson & Johnson Baby Powder prompted Johnson & Johnson to initiate a voluntary recall on approximately 33,000 bottles of the talcum […]READ MORE
Aug 29, 2019
Assistant U.S. Attorney Will Lewis to Join RPWB
COLUMBIA — Richardson, Patrick, Westbrook & Brickman, LLC is honored to announce that William Camden (Will) Lewis will be joining our law firm. He is presently employed at the U.S. Attorney’s Office for the District of South Carolina in Columbia, where he has worked as an Assistant U.S. Attorney for more than 3 years. After […]READ MORE
Aug 15, 2019
16 RPWB Lawyers Selected For Best Lawyers List
CHARLESTON – RPWB was once again the top-listed plaintiff law firm in South Carolina for product liability cases as well as mass tort and class action lawsuits in the 2020 edition of The Best Lawyers in America®, which was released in August 2019. In total, 16 RPWB attorneys were designated as 2020 Best Lawyers, including […]READ MORE
Jul 22, 2019
First New Mesothelioma Treatment in 15 Years Approved By FDA
By Ken Wilson It’s not often that we get to report new treatments for mesothelioma. While we do see a lot of clinical trials, the standard treatment plan for malignant pleural mesothelioma has been relatively unchanged for many years. Most patients go through surgery (if they are able to), radiation and chemotherapy. It can be […]READ MORE
Jun 10, 2019
When Personal Vaporizers Explode: An Entire Industry Designed Around the Wrong Battery
By Chris Moore Since the mid-2000s, we have become more reliant on lithium-ion batteries and the devices they power. The batteries are extremely useful and serve an important function. Just a decade ago, it would have been inconceivable for a laptop computer or a smartphone to be used for an entire day on just one […]READ MORE
May 23, 2019
RPWB Named To Leadership of 3M Combat Arms Ear Plug MDL
RPWB member attorney Elizabeth Middleton Burke was named to the leadership of the 3M Combat Arms Ear Plug multidistrict litigation. Federal lawsuits filed against 3M for producing faulty military ear plugs have been consolidated in the Northern District of Florida. Burke was named as co-chair of the Plaintiff Steering Committee, which builds the national product […]READ MORE
May 20, 2019
Richardson is a Top 25 Lawyer (Again!)
RPWB Founding Member Terry Richardson has been named as one of the top 25 lawyers in South Carolina by Super Lawyers, one of the nation’s premiere attorney rating services. This marks Richardson’s ninth time appearing on the list. For three consecutive years, he was ranked as one of the top 10 attorneys in the state. […]READ MORE
Apr 24, 2019
RPWB named to leadership of firefighting foam MDL
CHARLESTON, S.C. – RPWB has been named to the leadership of litigation to help the nation’s water utilities filter out harmful chemicals left behind by firefighting foam manufactured by 3M and Tyco. RPWB member Christiaan Marcum sits on the Plaintiff Executive Committee of the Aqueous Film-Forming Foam (AFFF) Multi-District Litigation, which has been consolidated in […]READ MORE
Mar 25, 2019
Supreme Court ruling will help asbestos victims
By Dave Butler The United States Supreme Court delivered an unexpectedly good opinion for asbestos victims last week. For years, equipment makers (including those who make pumps, valves, turbines and boilers) have argued that they only make and sell metal products and cannot be held responsible for asbestos products made by third parties and later […]READ MORE
Jan 18, 2019
RPWB welcomes a new member
Richardson, Patrick, Westbrook & Brickman is proud to announce that Aaron Dias has been named the firm’s newest member. Dias has spent the entirety of his legal career with RPWB, beginning as a clerk during law school. In 2005, he became an associate attorney at the firm. His practice focuses primarily on pharmaceutical and other […]READ MORE
Dec 03, 2018
Parties agree to settle SC nuclear plant class action
SCANA and SCE&G settle class action lawsuit with Attorney General and Plaintiffs Related to V.C. Summer Nuclear Costs Plaintiffs Richard Lightsey, LeBrian Cleckley, and Phillip Cooper have reached an agreement with SCANA Corporation and South Carolina Electric & Gas Company to settle a lawsuit filed in the state Court of Common Pleas in Hampton County on […]READ MORE
Nov 02, 2018
RPWB is a 2019 U.S. News Best Law Firm
CHARLESTON, S.C. – Richardson, Patrick, Westbrook & Brickman was named a 2019 Best Law Firm by U.S. News & World Report, recognizing the plaintiff firm for its work on mass torts and class actions, product liability, securities, healthcare law, medical malpractice and personal injury lawsuits. With 16 lawyers listed on the underlying Best Lawyers in […]READ MORE
Oct 24, 2018
The Role of the Whistleblower: A look at qui tam litigation
By Chuck Dukes Qui tam litigation allows private citizens, like you, to join in the battle against government fraud. Every year, many of our public institutions—from the military to Medicare—are plagued by fraud. Astonishingly, it’s estimated that nearly 10% of all federal spending, or $350–$400B per year, is lost due to fraud. And by and […]READ MORE
Sep 18, 2018
Families of two smokers hooked by free samples awarded $113 million
The families of a pair of deceased smokers from the United States Virgin Islands were awarded $113 million by two juries last month. In a consolidated trial, the juries found that the maker of Newport cigarettes (previously Lorillard, now R.J. Reynolds) engaged in a program to hook young people, including children, on cigarettes. The program […]READ MORE